Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 2,890,000 shares, a growth of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, the days-to-cover ratio […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 2,890,000 shares, a growth of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, the days-to-cover ratio […]
Harrow Health (NASDAQ:HROW – Get Rating) and HCW Biologics (NASDAQ:HCWB – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Valuation & Earnings This table compares Harrow Health and […]
Harrow Health (NASDAQ:HROW – Get Rating) and HCW Biologics (NASDAQ:HCWB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Risk and Volatility Harrow Health has a beta of […]
Corrado Advisors LLC lessened its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 14.9% during the fourth quarter, HoldingsChannel reports. The fund owned 16,314 shares of the company’s stock after selling 2,846 shares during the period. Corrado Advisors LLC’s holdings in Harrow Health were worth $241,000 at the end of the […]